Evidence map›Paper›PMID 24770419›Full record

ArticleThe Journal of biological chemistry2014

Inefficient translocation of preproinsulin contributes to pancreatic β cell failure and late-onset diabetes.

Huan Guo, Yi Xiong, Piotr Witkowski, Jingqing Cui, Ling-jia Wang, Jinhong Sun, Roberto Lara-Lemus, Leena Haataja, Kathryn Hutchison, Shu-ou Shan and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pathogenic signal peptide variants in the human genome.NAR genomics and bioinformatics · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Huan GuoFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105.
Yi XiongFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105.
Piotr Witkowskithe Division of Organ Transplantation, University of Chicago, Chicago, Illinois 60637.
Jingqing CuiFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105, the Division of Metabolism, Tianjin Medical University General Hospital, Tianjin, China 300052.
Ling-jia Wangthe Division of Organ Transplantation, University of Chicago, Chicago, Illinois 60637.
Jinhong SunFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105.
Roberto Lara-LemusFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105, the Department of Research in Biochemistry, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Mexico City 14080, Mexico, and.
Leena HaatajaFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105.
Kathryn HutchisonFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105.
Shu-ou Shanthe Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125 sshan@caltech.edu.
Peter ArvanFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105, parvan@umich.edu.
Ming LiuFrom the Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan 48105, the Division of Metabolism, Tianjin Medical University General Hospital, Tianjin, China 300052, mingli@umich.edu.
University of Michigan–Ann Arbor · USUniversity of Chicago · USCalifornia Institute of Technology · USTianjin Medical University General Hospital · CN

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Matthew J Brady · 2013 to 2026
$20.9M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
Molecular Mechanism of Protein Targeting by the Signal Recognition ParticleR01GM078024 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI SHAN, SHU-OU · 2007 to 2020
$4.4M
Preproinsulin Translocation and Processing at the ER Membrane: a link to DiabetesR01DK088856 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIU, MING · 2011 to 2015
$1.4M
NCATS NIH HHS UL1 TR000430NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK020595NIDDK NIH HHS P30-DK020595NIDDK NIH HHS P60 DK020572NIDDK NIH HHS P60-DK-20572NIDDK NIH HHS R01 DK048280NIDDK NIH HHS R01 DK088856NIDDK NIH HHS R01-DK088856NIDDK NIH HHS R01-DK-48280NIGMS NIH HHS R01 GM078024
6 · The paper itself

Abstract

Among the defects in the early events of insulin biosynthesis, proinsulin misfolding and endoplasmic reticulum (ER) stress have drawn increasing attention as causes of β cell failure. However, no studies have yet addressed potential defects at the cytosolic entry point of preproinsulin into the secretory pathway. Here, we provide the first evidence that inefficient translocation of preproinsulin (caused by loss of a positive charge in the n region of its signal sequence) contributes to β cell failure and diabetes. Specifically, we find that, after targeting to the ER membrane, preproinsulin signal peptide (SP) mutants associated with autosomal dominant late-onset diabetes fail to be fully translocated across the ER membrane. The newly synthesized, untranslocated preproinsulin remains strongly associated with the ER membrane, exposing its proinsulin moiety to the cytosol. Rather than accumulating in the ER and inducing ER stress, untranslocated preproinsulin accumulates in a juxtanuclear compartment distinct from the Golgi complex, induces the expression of heat shock protein 70 (HSP70), and promotes β cell death. Restoring an N-terminal positive charge to the mutant preproinsulin SP significantly improves the translocation defect. These findings not only reveal a novel molecular pathogenesis of β cell failure and diabetes but also provide the first evidence of the physiological and pathological significance of the SP n region positive charge of secretory proteins.

Indexed as

Amino Acid SequenceAnimalsDiabetes MellitusEndoplasmic ReticulumHumansInsulinIslets of LangerhansMiceMolecular Sequence DataProtein PrecursorsProtein TransportRatsSequence Homology, Amino AcidInsulinpreproinsulinProtein PrecursorsCytosolic Protein AccumulationDiabetesInsulin SynthesisMutantPreproinsulinProinsulinProtein Translocationβ Cell

Identifiers

PMID24770419
PMCPMC4047398
OpenAlexW2069247329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.